We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Discovery To Commence In Invitrogen Patent Case

Law360 (October 4, 2007, 12:00 AM EDT) -- Life sciences company Invitrogen Corp. has won the go-ahead to commence limited discovery in a lawsuit that accuses Harvard College's top guardians of wrongly laying claim to a molecular cloning patent.

In an order issued Thursday, Magistrate Judge Louisa S. Porter of the U.S. District Court for the Southern District of California said Invitrogen was not required to establish a prima facie case of personal jurisdiction prior to conducting discovery.

However, she did say Invitrogen's discovery requests were overly burdensome, and therefore partially granted Harvard's motion...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.